Clinical Trials Arena on MSN
Regeneron’s trial fails to reach statistical significance for primary endpoint
The double-blind, randomised trial tested two dosing regimens against a pembrolizumab monotherapy.
Statistical fragility refers to the vulnerability of clinical trial results to minor changes in event outcomes. The fragility index quantifies this vulnerability by determining the minimum number of ...
Every research lab is constantly innovating; either by creating something new or by understanding the equations and statistics underlying each vital subject, the stakes are high. With trillions of ...
- Achieved statistical significance versus standard-of-care (SOC) control across all key efficacy endpoints in the 52-week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results